573 related articles for article (PubMed ID: 8998184)
1. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
2. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
4. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
Lerman C; Hughes C; Benkendorf JL; Biesecker B; Kerner J; Willison J; Eads N; Hadley D; Lynch J
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):361-7. PubMed ID: 10207641
[TBL] [Abstract][Full Text] [Related]
6. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
Schwartz MD; Benkendorf J; Lerman C; Isaacs C; Ryan-Robertson A; Johnson L
Cancer; 2001 Aug; 92(4):932-40. PubMed ID: 11550168
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.
Calzone KA; Prindiville SA; Jourkiv O; Jenkins J; DeCarvalho M; Wallerstedt DB; Liewehr DJ; Steinberg SM; Soballe PW; Lipkowitz S; Klein P; Kirsch IR
J Clin Oncol; 2005 May; 23(15):3455-64. PubMed ID: 15908654
[TBL] [Abstract][Full Text] [Related]
9. Testing for hereditary breast and ovarian cancer in the southeastern United States.
Miron A; Schildkraut JM; Rimer BK; Winer EP; Sugg Skinner C; Futreal PA; Culler D; Calingaert B; Clark S; Kelly Marcom P; Iglehart JD
Ann Surg; 2000 May; 231(5):624-34. PubMed ID: 10767783
[TBL] [Abstract][Full Text] [Related]
10. Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Skinner CS; Schildkraut JM; Berry D; Calingaert B; Marcom PK; Sugarman J; Winer EP; Iglehart JD; Futreal PA; Rimer BK
Genet Test; 2002; 6(2):93-105. PubMed ID: 12215248
[TBL] [Abstract][Full Text] [Related]
11. Screening for 185delAG in the Ashkenazim.
Richards CS; Ward PA; Roa BB; Friedman LC; Boyd AA; Kuenzli G; Dunn JK; Plon SE
Am J Hum Genet; 1997 May; 60(5):1085-98. PubMed ID: 9150156
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
13. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Nelson HD; Huffman LH; Fu R; Harris EL;
Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
[TBL] [Abstract][Full Text] [Related]
17. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
[TBL] [Abstract][Full Text] [Related]
19. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
Barnes-Kedar IM; Plon SE
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
[TBL] [Abstract][Full Text] [Related]
20. The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.
Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
J Genet Couns; 2004 Jun; 13(3):237-57. PubMed ID: 15604634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
